Literature DB >> 34802304

T-cell lymphoma-associated hemophagocytic syndrome in an American Pit Bull Terrier.

Dominique A Hemmings1, Athema L Etzioni2, Gbemisola Akingbade2, Fredrick E Tippett2.   

Abstract

A 3-y-old, intact female, American Pit Bull Terrier was presented because of acute onset of anorexia and a large subcutaneous submandibular mass that had been present for 3 wk. The submandibular mass, 2 engorged black-legged ticks on the dorsum of the neck, pyrexia, and icterus were seen on physical examination. Abnormal laboratory test results included a positive Anaplasma antibody test, severe thrombocytopenia, mild nonregenerative anemia, hyperbilirubinemia, and elevated liver enzyme activities. Cytology of the mass was interpreted as marked septic purulent inflammation with acute hemorrhage. Treatment with doxycycline for anaplasmosis was unsuccessful, and the patient died at an emergency follow-up visit 2 d after the initial presentation. Autopsy and histopathology revealed widespread metastasis of a presumptive histiocytic neoplasm with associated hemophagocytosis seen in lymph nodes (LNs), liver, and spleen. Immunohistochemistry yielded a definitive diagnosis of a CD3+/CD18+ T-cell lymphoma. In this case of canine lymphoma-associated hemophagocytic syndrome, hemophagocytes were observed as >2% of neoplastic cells in the liver, spleen, and LN histologically, a scarce or unreported finding, to our knowledge. The prognosis was grave, with a short survival time after the onset of clinical signs.

Entities:  

Keywords:  anaplasmosis; dogs; erythrophagocytosis; immunohistochemistry; lymphoma

Mesh:

Year:  2021        PMID: 34802304      PMCID: PMC8921800          DOI: 10.1177/10406387211061264

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  14 in total

1.  B-cell lymphoma in a dog with ehrlichiosis (Ehrlichia canis) and systemic histoplasmosis (Histoplasma capsulatum).

Authors:  Jill D Brunker; John P Hoover
Journal:  Can Vet J       Date:  2007-03       Impact factor: 1.008

2.  Canine lymphoma and vector-borne diseases: Molecular and serological evaluation of a possible complicity.

Authors:  Joaquim Henriques; Ricardo Felisberto; Bruno Almeida; Joana Ramos; Fernando Constantino-Casas; Jane Dobson; Raquel Matos; Ana Santos; Rita de Sousa; Margarida Alves
Journal:  Vet Comp Oncol       Date:  2020-11-03       Impact factor: 2.613

Review 3.  A review of histiocytic diseases of dogs and cats.

Authors:  P F Moore
Journal:  Vet Pathol       Date:  2014-01       Impact factor: 2.221

4.  Atypical cytologic presentation of a histiocytic sarcoma in a Cavalier King Charles Spaniel dog.

Authors:  Lorelei L Clarke; Lisa S Kelly; Bridget Garner; Cathy A Brown
Journal:  J Vet Diagn Invest       Date:  2017-04-05       Impact factor: 1.279

5.  Hemophagocytic syndrome in dogs: 24 cases (1996-2005).

Authors:  Douglas J Weiss
Journal:  J Am Vet Med Assoc       Date:  2007-03-01       Impact factor: 1.936

6.  Extranodal gammadelta-T-cell lymphoma in a dog with leishmaniasis.

Authors:  Valentina Foglia Manzillo; Annalisa Pagano; Roberta Guglielmino; Luigi Gradoni; Brunella Restucci; Gaetano Oliva
Journal:  Vet Clin Pathol       Date:  2008-09       Impact factor: 1.180

7.  Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution.

Authors:  Jui-Ting Yu; Chen-Yu Wang; Youngsen Yang; Ren-Ching Wang; Kuang-Hsi Chang; Wen-Li Hwang; Chieh-Lin Jerry Teng
Journal:  Ann Hematol       Date:  2013-05-23       Impact factor: 3.673

8.  Hemophagocytic Lymphohistiocytosis Associated with Anaplasmosis.

Authors:  Tamara M Johnson; Melinda S Brown; Mohamed Rabbat; Jihad Slim
Journal:  J Glob Infect Dis       Date:  2017 Apr-Jun

Review 9.  Canine Histiocytic Malignancies-Challenges and Opportunities.

Authors:  Katherine Kennedy; Rachael Thomas; Matthew Breen
Journal:  Vet Sci       Date:  2016-01-04

10.  Lymphoma-associated hemophagocytic syndrome in six dogs.

Authors:  Akihisa Suwa; Tetsuya Shimoda
Journal:  J Vet Med Sci       Date:  2018-06-25       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.